CEE unquote" May 2012
CVC’s sale of StarBev is the second strong exit so far this year in CEE – the flotation of AVG on the NYSE was the first PE-backed IPO of a European business in 10 months.
Together, these two exits should help re-convince institutional investors of the merits of the region.
In the May edition of CEE unquote":
- The rise of the bond
- Lack of metrics stall social investment
- Carried interest controversy
- And more...
Download the latest edition of CEE unquote" now!
More on CEE
Re-Pie to raise single-asset fund for Muslim fashion retailer
Turkish GP will onboard investors to the fund until 31 May; proceeds will back Modanisa’s expansion
Tikehau, Unilever, Axa form EUR 1bn impact fund
Each party has made a EUR 100m commitment and the agriculture-focused fund is now open to new LPs
Schroders gears up for new VC fund-of-funds
Schroders Capital Private Equity Global Innovation Management XI has been registered in Luxembourg
LongeVC mulls 2023 fundraise for second fund
Biotech-focused VC could hit the road for new USD 180m-200m vehicle once Fund I’s hard-cap is reached
Latest News
FSN Capital acquires Epista Life Sciences
The GP said it will pursue a buy-and-build strategy in the life science IT services sector
Advent Life Sciences hires three partners
Dominic Schmidt is based in the UK, while Satish Jindal and Katrine Bosley join in the US
Five Arrows kicks off Laf Santé sale
Five Arrows has owned a majority stake in the France-based low-cost pharmacy chain since 2016
Hg’s MEDIFOX sale launch draws large-cap sponsor interest
Hg acquired the software platform for care providers in 2018 from ECM Equity Capital Management
